Table 1.
Characteristics |
Preguideline n=1085 |
Postguideline n=721 | Chi-Square |
---|---|---|---|
n (%) | n (%) | P | |
Age group, years | 0.007* | ||
18–20 | 169 (15) | 95 (13) | |
21–25 | 408 (38) | 234 (33) | |
26+ | 508 (47) | 392 (54) | |
Race or ethnicity | 0.08 | ||
Hispanic | 321 (30) | 233 (32) | |
Black | 377 (35) | 222 (31) | |
White | 307 (28) | 226 (31) | |
Other | 80 (7) | 40 (6) | |
Language | 0.23 | ||
English | 768 (71) | 518 (72) | |
Spanish | 188 (17) | 135 (19) | |
Other | 129 (12) | 68 (9) | |
Index abnormality | 0.11 | ||
LSIL | 992 (91) | 674 (93) | |
HSIL | 93 (9) | 47 (7) | |
Insurance status | 0.06 | ||
Uninsured | 343 (32) | 194 (27) | |
Public | 395 (36) | 296 (41) | |
Private | 347 (32) | 231 (32) | |
Clinical site | [lt]0.01* | ||
A | 250 (23) | 216 (30) | |
B | 254 (24) | 161 (22) | |
C | 69 (6) | 41 (6) | |
D | 118 (11) | 94 (13) | |
E | 209 (19) | 161 (22) | |
F | 185 (17) | 48 (7) |
Some observed differences may be due to differences in data collection: data collected in 2004–2005 (baseline and feasibility study) included all patients with high grade lesions and a random selection of patients with low grade lesions, while data from 2007–2008 (intervention) included all patients with abnormal Pap tests.